Bioanalytical platform comparison using a generic human IgG PK assay format

Journal of Immunological Methods

Volumn 397, Issue 1-2, 2013, Pages 28-36

  Leary, Beth A ^a   Lawrence Henderson, Rosemary ^a   Mallozzi, Carolyn ^b   Fernandez Ocaña, Mireia ^a   Duriga, Nicole ^a   O'Hara, Denise M ^a   Kavosi, Mania ^a   Qu, Qiang ^a   Joyce, Alison P ^a  

^a PFIZER INC   (United States)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Generic IgG assay; Immunoaffinity; Immunoassay; Ligand binding assay (LBA); Mass spectrometry

Indexed keywords

IMMUNOGLOBULIN G;

ANTIBODY AFFINITY; ARTICLE; BINDING ASSAY; COMPARATIVE STUDY; CONTROLLED STUDY; COST; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LIGAND BINDING; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEASUREMENT ACCURACY; MEDICAL DEVICE; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RAT; SENSITIVITY ANALYSIS;

GENERIC IGG ASSAY; IMMUNOAFFINITY; IMMUNOASSAY; LIGAND-BINDING ASSAY (LBA); MASS SPECTROMETRY;

ANIMALS; ANTIBODIES, MONOCLONAL; CHROMATOGRAPHY, LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; RATS; TANDEM MASS SPECTROMETRY;

GYROS; RATTUS;

EID: 84885950943     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2013.08.009     Document Type: Article

References (11)

1. Dubois M., Fenaille F., Clement G., Lechmann M., Tabet J.C., Ezan E., Becher F. Immunopurification and mass spectrometric quantification of the active form of a chimeric therapeutic antibody in human serum. Anal. Chem. 2008, 80:1737.
2. Fernandez Ocaña M., James I.T., Kabir M., Grace C., Yuan G., Martin S.W., Neubert H. Clinical pharmacokinetic assessment of an anti-MAdCAM monoclonal antibody therapeutic by LC-MS/MS. Anal. Chem. 2012, 84:5959.
3. Heudi O., Barteau S., Zimmer D., Schmidt J., Bill K., Lehmann N., Bauer C., Kretz O. Towards absolute quantification of therapeutic monoclonal antibody in serum by LC-MS/MS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry. Anal. Chem. 2008, 80:4200.
4. Kuhle J., Regeniter A., Leppert D., Mehling M., Kappos L., Lindberg R.L., Petzold A. A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein. J. Neuroimmunol. 2010, 220:114.
5. Li H., Ortiz R., Tran L., Hall M., Spahr C., Walker K., Laudemann J., Miller S., Salimi-Moosavi H., Lee J.W. General LC-MS/MS method approach to quantify therapeutic monoclonal antibodies using a common whole antibody internal standard with application to preclinical studies. Anal. Chem. 2012, 84:1267.
6. Liu X.F., Wang X., Weaver R.J., Calliste L., Xia C., He Y.J., Chen L. Validation of a Gyrolab assay for quantification of rituximab in human serum. J. Pharmacol. Toxicol. Methods 2012, 65:107.
7. Neubert H., Muirhead D., Kabir M., Grace C., Cleton A., Arends R. Sequential protein and peptide immunoaffinity capture for mass spectrometry-based quantification of total human beta-nerve growth factor. Anal. Chem. 2013, 85:1719.
8. Poulsen F., Jensen K.B. A luminescent oxygen channeling immunoassay for the determination of insulin in human plasma. J. Biomol. Screen. 2007, 12:240.
9. Soderstrom C.I., Spriggs F.P., Song W., Burrell S. Comparison of four distinct detection platforms using multiple ligand binding assay formats. J. Immunol. Methods 2011, 371:106.
10. Wang S.J., Wu S.T., Gokemeijer J., Fura A., Krishna M., Morin P., Chen G., Price K., Wang-Iverson D., Olah T., Weiner R., Tymiak A., Jemal M. Attribution of the discrepancy between ELISA and LC-MS/MS assay results of a PEGylated scaffold protein in post-dose monkey plasma samples due to the presence of anti-drug antibodies. Anal. Bioanal. Chem. 2012, 402:1229.
11. Yohrling J. Ligand-binding assays: risk of using a platform supported by a single vendor. Bioanalysis 2009, 1(3):629.